Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2002
07/11/2002WO2001029266A3 Identification of arsacs mutations and methods of use therefor
07/11/2002WO2001029257A3 Methods of genetic cluster analysis
07/11/2002WO2001029054A3 Medicaments for treatment of respiratory syncytial virus infections
07/11/2002WO2001020018A3 Diagnosing and treating arthritic disorders
07/11/2002WO2001019981A3 Functional genomics using zinc finger proteins
07/11/2002WO2001016371A3 Method for identifying nucleic acid base phosphoramidites by fluorescence spectroscopy
07/11/2002WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
07/11/2002WO2001011086A9 Methods of screening for angiogenesis modulators
07/11/2002WO2001011081A3 Microbial polynucleotides expressed during infection of a host
07/11/2002WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9
07/11/2002WO2001010205A9 Methods and materials relating to cd39-like polypeptides
07/11/2002WO2001009383A3 Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
07/11/2002WO2001007665A9 Sequence determination of nucleic acids using electronic detection
07/11/2002WO2001007661A3 Polynucleotide amplification method
07/11/2002WO2001007650A3 Improvements in and relating to forensic investigations
07/11/2002WO2001006016A9 Amplification of nucleic acids with electronic detection
07/11/2002WO2001000138A3 Use of hydroxydiphenyl ether class of chemicals, as exemplified by triclosan, as an antimalarial and identification of fatty acid synthesis as its target
07/11/2002WO2000078996A9 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
07/11/2002WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease
07/11/2002WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression
07/11/2002WO2000061816A9 Electronically mediated nucleic acid amplification in nasba
07/11/2002WO2000060118A3 Electrophoretic analysis of target molecules using adapter molecules
07/11/2002WO2000058730A9 Method and device for detecting analytes in fluids
07/11/2002WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
07/11/2002WO2000056762A3 Methods for monitoring multiple gene expression
07/11/2002WO2000053812A3 Replica amplification of nucleic acid arrays
07/11/2002WO2000052194A9 Methods for detecting membrane derived caspase activity and modulators thereof
07/11/2002US20020092040 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1, 4 glucans in plants, fungi and microorganisms
07/11/2002US20020092036 Plant for use as tool in the generation of heterologous proteins
07/11/2002US20020091664 Methods for measuring therapy resistance
07/11/2002US20020091250 Metabotropic GABA [B] receptors, receptor-specific ligands and their uses
07/11/2002US20020091249 Human tumor suppressor polypeptides
07/11/2002US20020091247 Polycyclic aromatic hydrocarbon induced molecules
07/11/2002US20020091245 Process for immobilization of nucleic acid molecules on a substrate
07/11/2002US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders
07/11/2002US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia
07/11/2002US20020091086 Peptides that block viral infectivity and methods of use thereof
07/11/2002US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB.
07/11/2002US20020091073 Method to limit immunodeficiency virus infection and compounds therefor
07/11/2002US20020091072 Endothelin converting enzymes and the amyloid beta peptide
07/11/2002US20020090738 System and method of microdispensing and arrays of biolayers provided by same
07/11/2002US20020090723 Generating preferential cell cultures; isolate blastocyst, culture, recover cells
07/11/2002US20020090712 Rab proteins
07/11/2002US20020090707 Promoter sequences
07/11/2002US20020090706 Nucleotide sequences coding polypeptides for the use in the treatment of cancer, autoimmune disease and cardiovascular disorders
07/11/2002US20020090703 Mammalian protein phosphatases
07/11/2002US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
07/11/2002US20020090693 Novel human sodium-dependent phosphate cotransporter
07/11/2002US20020090676 TNF receptors, TNF binding proteins and DNAs coding for them
07/11/2002US20020090673 Nucleic acids, proteins, and antibodies
07/11/2002US20020090672 Nucleic acids, proteins, and antibodies
07/11/2002US20020090668 Broths for use in the detection of preferential biopolymers
07/11/2002US20020090666 Methods for detecting membrane derived caspase activity and modulators thereof
07/11/2002US20020090660 Helicobacter pylori antigens in blood
07/11/2002US20020090659 Detection and visualization of neoplastic tissues and other tissues
07/11/2002US20020090653 Methods of treating pervasive development disorders
07/11/2002US20020090643 Compositions and methods for monitoring the phosphorylation of natural binding partners
07/11/2002US20020090641 Separation of nucleotide sequences on solid support; obtain sample, incubate with solid support, recover nucleotide sequences
07/11/2002US20020090640 DNA chip and its preparation
07/11/2002US20020090639 Two dimensional linkage study methods and related inventions
07/11/2002US20020090638 Stabilization of particles and reduction of sample discordance in immunoassays using casein coating of particles
07/11/2002US20020090636 Screening nucleotide sequences samples; obtain nucleotide sequences, incubate with primers, amplify nucleotide sequences, analyzing amplified nucleotide sequences
07/11/2002US20020090635 Compositions and methods for the release of nucleic acid molecules from solid matrices
07/11/2002US20020090634 Sequence determination of preferential nucleotide sequences; obtain nuclelotide sequences, electrophorese, determine sequence of nucleic acids
07/11/2002US20020090633 Molecular torches
07/11/2002US20020090630 Method of sequence determination for nucleic acid
07/11/2002US20020090629 Digital amplification
07/11/2002US20020090628 Nucleotide sequences for use as diagnostic tools in genetic engineering
07/11/2002US20020090627 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of brain, heart, pain, metabolic, immunological and cell proliferative disorders
07/11/2002US20020090626 Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria
07/11/2002US20020090624 Gene markers useful for detecting skin damage in response to ultraviolet radiation
07/11/2002US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control
07/11/2002US20020090621 Oligonucleotides for use in the detection of preferential nucleotide sequences in sample
07/11/2002US20020090620 Identification of drugs and drug targets by detection of the stress response
07/11/2002US20020090617 Detecting preferential nucleotide sequences in sample; obtain sample, incubate with probe, hybridize, adjust hydrogen ion concentration, detect bound probe, elute target nucleotide sequences
07/11/2002US20020090616 Electrophretic probes for detection and monitoring ligand binding activity
07/11/2002US20020090615 Nucleic acids, proteins, and antibodies
07/11/2002US20020090614 Direct measurement method for gene expression using single chain antisense array
07/11/2002US20020090613 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
07/11/2002US20020090612 Detection of preferential nucleotide sequences in sample; obtain sample, incubate with probes, record pattern, compare to control
07/11/2002US20020090611 Detection of human immunodeficiency virus
07/11/2002US20020090605 Detecting cell preferential regulatory sequences; obtain cells,transform cells, recover cells expressing preferential reporter gene
07/11/2002US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
07/11/2002US20020090320 Provides flexibility, robustness, accuracy
07/11/2002US20020089060 Semiconductor device with porous interlayer insulating film
07/11/2002US20020088181 Remote control gate
07/11/2002DE10147232A1 Polymerase chain reaction mixture, useful e.g. for genomic analysis, includes bovine serum albumin, allowing reduction in concentration of polymerase and fluorescent reagents
07/11/2002DE10100122A1 Verfahren zur Bestimmung der Hautalterung in vitro Method for determining the aging of the skin in vitro
07/11/2002DE10065815A1 Solid-phase synthesis of oligonucleotide array, useful e.g. for analyzing cytosine methylation patterns, comprises alternating application of monomer and deprotecting reagent
07/11/2002DE10065814A1 Verfahren für die simultane Amplifikation vieler Sequenzen in einer PCR-Reaktion und deren Markierung A method for simultaneous amplification of many sequences in a PCR reaction and the marker
07/11/2002DE10065666A1 DNA-Chip zur kausalen Diagnose von Bluthochdruck DNA chip for the causal diagnosis of high blood pressure
07/11/2002CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use
07/11/2002CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto
07/11/2002CA2434120A1 Detection of pathogenic bacteria
07/11/2002CA2433782A1 Proteins and nucleic acids encoding same
07/11/2002CA2433674A1 Method for relative quantification of attached nucleic acids
07/11/2002CA2433634A1 5'-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
07/11/2002CA2433628A1 Enzymatic deprotection of amines and hydroxides
07/11/2002CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/11/2002CA2433446A1 Inhibitors of memapsin 2 and use thereof